Literature DB >> 9307193

An excess of testicular germ cell tumors in Down's syndrome: three case reports and a review of the literature.

D Satgé1, A J Sasco, H Curé, B Leduc, D Sommelet, M J Vekemans.   

Abstract

BACKGROUND: The incidence of specific solid tumors in Down's syndrome (DS) is not well established. Testicular germ cell tumors (TGCT) might be increased in this population.
METHODS: The presence of TGCT among male subjects from the French department of Corrèze was recorded and literature on the subject reviewed.
RESULTS: A total of 120 living children and adults with DS and 17 pregnancies (12 births and 5 therapeutic abortions) were examined over an 8-year period (1987-1994). Three TGCT were diagnosed. A seminoma and an embryonal carcinoma were observed in two young adults and an intratubular germ cell neoplasm in a 22-week-old fetus. Because testicular tumors occur at an incidence rate of 4 cases per 100,000 person-years in the general population, these observations suggest a clearly increased risk of developing TGCT in the DS population. In addition, a review of the literature also shows an excess of TGCT in this population. Cryptorchidism alone, which is prevalent in individuals with DS, cannot explain this significantly increased incidence of TCGT. The authors hypothesize that an excess of luteinizing hormone and follicle-stimulating hormone gonadotropins and overexpression of the Ets-2 gene through gene dosage effect could predispose patients with DS to the development of TGCT.
CONCLUSIONS: Surveillance of the gonads of male patients with DS is recommended. A better understanding of the factors involved could also help to identify risk factors in the general population.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9307193

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

Review 1.  Clinical epidemiology of testicular germ cell tumors.

Authors:  K-P Dieckmann; U Pichlmeier
Journal:  World J Urol       Date:  2004-03-18       Impact factor: 4.226

2.  Treatment experiences of testicular cancer in Hispanic patients with Down's syndrome at the National Cancer Institute of Mexico.

Authors:  Jose Luis Aguilar-Ponce; Silvia Vidal-Millán; Carlos Molina-Calzada; Fatima Chilaca-Rosas; Jorge Martínez-Cedillo; Juan Carlos Cruz-López
Journal:  Clin Transl Oncol       Date:  2008-11       Impact factor: 3.405

3.  Identification of Down's syndrome critical locus gene SIM2-s as a drug therapy target for solid tumors.

Authors:  Maurice Phil DeYoung; Matthew Tress; Ramaswamy Narayanan
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-03       Impact factor: 11.205

Review 4.  Diagnosis and treatment of patients with testicular germ cell cancer.

Authors:  J T Hartmann; L Kanz; C Bokemeyer
Journal:  Drugs       Date:  1999-08       Impact factor: 9.546

Review 5.  Constitutional aneuploidy and cancer predisposition.

Authors:  Ithamar Ganmore; Gil Smooha; Shai Izraeli
Journal:  Hum Mol Genet       Date:  2009-04-15       Impact factor: 6.150

Review 6.  Etiologic factors in testicular germ-cell tumors.

Authors:  Katherine A McGlynn; Michael B Cook
Journal:  Future Oncol       Date:  2009-11       Impact factor: 3.404

7.  Loss of singleminded-2s in the mouse mammary gland induces an epithelial-mesenchymal transition associated with up-regulation of slug and matrix metalloprotease 2.

Authors:  Brian Laffin; Elizabeth Wellberg; Hyeong-Il Kwak; Robert C Burghardt; Richard P Metz; Tanya Gustafson; Pepper Schedin; Weston W Porter
Journal:  Mol Cell Biol       Date:  2007-12-26       Impact factor: 4.272

8.  Epstein-Barr virus-related post-transplant lymphoproliferative disorder occurring after bone marrow transplantation for aplastic anemia in Down's syndrome.

Authors:  Aya Furuya; Mitsuaki Ishida; Keiko Hodohara; Miyuki Yoshii; Hiroko Okuno; Akiko Horinouchi; Ryota Nakanishi; Ayumi Harada; Muneo Iwai; Keiko Yoshida; Akiko Kagotani; Takashi Yoshida; Hidetoshi Okabe
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

9.  Genetic variation in the inhibin pathway and risk of testicular germ cell tumors.

Authors:  Mark P Purdue; Barry I Graubard; Stephen J Chanock; Mark V Rubertone; Ralph L Erickson; Katherine A McGlynn
Journal:  Cancer Res       Date:  2008-04-15       Impact factor: 12.701

10.  Clinical and genetic aspects of testicular germ cell tumours.

Authors:  Martijn F Lutke Holzik; Rolf H Sijmons; Josette Ehm Hoekstra-Weebers; Dirk T Sleijfer; Harald J Hoekstra
Journal:  Hered Cancer Clin Pract       Date:  2008-02-15       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.